Evdokia Anagnostou

From WikiMD's Wellness Encyclopedia

Evdokia Anagnostou is a pediatric neurologist and senior clinician scientist at the Bloorview Research Institute and the co-lead of the Autism Research Centre in Toronto, Canada. Her research focuses on understanding the neurobiology of autism and related neurodevelopmental disorders in order to develop targeted treatments.

Early Life and Education[edit | edit source]

Anagnostou completed her medical degree at the University of Patras, Greece. She then moved to the United States for her residency in Pediatrics at the State University of New York at Buffalo. She completed her fellowship in Child Neurology and a research fellowship in Movement Disorders at the Boston Children's Hospital, Harvard Medical School.

Career and Research[edit | edit source]

Anagnostou's research primarily focuses on the neurobiology of autism and related neurodevelopmental disorders. She is interested in understanding the genetic and environmental factors that contribute to the development of these disorders, and how these factors influence brain development and function. Her work involves the use of advanced neuroimaging techniques, genomic analyses, and clinical trials to investigate these questions.

She is also involved in the development of novel therapeutic approaches for autism and related disorders. This includes the use of pharmacological treatments, as well as non-pharmacological interventions such as behavioral therapy and neurofeedback.

Honors and Awards[edit | edit source]

Anagnostou has received several awards for her work, including the NARSAD Young Investigator Grant from the Brain & Behavior Research Foundation, and the Career Development Award from the American Academy of Neurology.

References[edit | edit source]


External Links[edit | edit source]


WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD